NDC 43742-1619 Euphorbium Officinarum, Luffa Operculata, Plantago Major, Pulsatilla (pratensis), Caffeic Acid, Caffeic Acid, Coumarinum, Eugenol, Gallicum Acidum, Histaminum Hydrochloricum, Indolum, Quercetin, Rutin, Mercurius Iodatus Ruber, Mucosa Nasalis Suis, Argentum Nitricum, Hepar Sulphuris Calcareum, Chlorogenic Acid, Sinusitisinum, House Dust Mite, Malvin, American Elm, Plane (sycamore), Ash, Beech, Willow, Elder (box Elder), Alder, Cedar, Maple, Hazel, Poplar, Kentucky Bluegrass, Orchard Grass, Silver Birch, Oak,
Liquid - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Code Structure Chart
Product Details
What is NDC 43742-1619?
What are Euphorbium Officinarum, Luffa Operculata, Plantago Major, Pulsatilla (pratensis), Caffeic Acid, Caffeic Acid, Coumarinum, Eugenol, Gallicum Acidum, Histaminum Hydrochloricum, Indolum, Quercetin, Rutin, Mercurius Iodatus Ruber, Mucosa Nasalis Suis, Argentum Nitricum, Hepar Sulphuris Calcareum, Chlorogenic Acid, Sinusitisinum, House Dust Mite, Malvin, American Elm, Plane (sycamore), Ash, Beech, Willow, Elder (box Elder), Alder, Cedar, Maple, Hazel, Poplar, Kentucky Bluegrass, Orchard Grass, Silver Birch, Oak, Active Ingredients?
- ACER SACCHARUM POLLEN 12 [hp_X]/mL
- ALNUS RUBRA POLLEN 12 [hp_X]/mL
- ANEMONE PRATENSIS 6 [hp_X]/mL
- ANTHOXANTHUM ODORATUM POLLEN 12 [hp_X]/mL
- BETULA PENDULA POLLEN 12 [hp_X]/mL
- CAFFEIC ACID 6 [hp_X]/mL
- CALCIUM SULFIDE 10 [hp_X]/mL
- CARYA GLABRA POLLEN 12 [hp_X]/mL
- CHLOROGENIC ACID 12 [hp_X]/mL - A naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. (From J Chromatogr A 1996;741(2):223-31; Biosci Biotechnol Biochem 1996;60(5):765-68).
- CORYLUS AVELLANA POLLEN 12 [hp_X]/mL
- COUMARIN 6 [hp_X]/mL
- CYNODON DACTYLON POLLEN 12 [hp_X]/mL
- DACTYLIS GLOMERATA POLLEN 12 [hp_X]/mL
- DERMATOPHAGOIDES FARINAE 9 [hp_C]/mL - Species of American house dust mite, in the family PYROGLYPHIDAE.
- EUGENOL 6 [hp_X]/mL - A cinnamate derivative of the shikimate pathway found in CLOVE OIL and other PLANTS.
- EUPHORBIA RESINIFERA RESIN 6 [hp_X]/mL
- FAGUS SYLVATICA POLLEN 12 [hp_X]/mL
- FRAXINUS EXCELSIOR POLLEN 12 [hp_X]/mL
- GALLIC ACID MONOHYDRATE 6 [hp_X]/mL
- HISTAMINE DIHYDROCHLORIDE 6 [hp_X]/mL - An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
- INDOLE 6 [hp_X]/mL
- JUNIPERUS VIRGINIANA POLLEN 12 [hp_X]/mL
- LUFFA OPERCULATA FRUIT 6 [hp_X]/mL
- MALVIN 12 [hp_C]/mL
- MERCURIC IODIDE 8 [hp_X]/mL
- PASPALUM NOTATUM POLLEN 12 [hp_X]/mL
- PHLEUM PRATENSE POLLEN 12 [hp_X]/mL
- PLANTAGO MAJOR 6 [hp_X]/mL
- PLATANUS X ACERIFOLIA POLLEN 12 [hp_X]/mL
- POA PRATENSIS POLLEN 12 [hp_X]/mL
- POPULUS ALBA POLLEN 12 [hp_X]/mL
- QUERCETIN 6 [hp_X]/mL - A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.
- QUERCUS ROBUR POLLEN 12 [hp_X]/mL
- RUTIN 6 [hp_X]/mL - A flavonol glycoside found in many plants, including BUCKWHEAT; TOBACCO; FORSYTHIA; HYDRANGEA; VIOLA, etc. It has been used therapeutically to decrease capillary fragility.
- SALIX X FRAGILIS POLLEN 12 [hp_X]/mL
- SAMBUCUS CANADENSIS FLOWER 12 [hp_X]/mL
- SECALE CEREALE POLLEN 12 [hp_X]/mL
- SILVER NITRATE 10 [hp_X]/mL - A silver salt with powerful germicidal activity. It has been used topically to prevent OPHTHALMIA NEONATORUM.
- SINUSITISINUM 18 [hp_X]/mL
- SORGHUM HALEPENSE POLLEN 12 [hp_X]/mL
- SUS SCROFA NASAL MUCOSA 8 [hp_X]/mL
- ULMUS AMERICANA POLLEN 12 [hp_X]/mL
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
[13] What is an Unfinished Product? - This field indicates if the product is an unfinished drug. An unfinished drug is an active pharmaceutical ingredient either alone or with other ingredients that is not a finished drug product. Unfinished drugs are used to process other drugs or for drug compounding.